-
PurposeRetroviral vector for expression of human MAVS in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 52135 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepMSCV2.2 IRES GFP
- Backbone size w/o insert (bp) 6600
- Total vector size (bp) 8200
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersGFP
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameMAVS
-
Alt nameIPS-I
-
Alt nameVISA
-
Alt nameCARDIF
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1600
-
GenBank IDBC044952 AAH44952.1
-
Entrez GeneMAVS (a.k.a. CARDIF, IPS-1, IPS1, VISA)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer pMSCV forward
- 3′ sequencing primer MAVS scn (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byZJ Chen provided HA-MAVS in pEF
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MAVS-WT was a gift from Jonathan Kagan (Addgene plasmid # 52135 ; http://n2t.net/addgene:52135 ; RRID:Addgene_52135) -
For your References section:
Peroxisomes are signaling platforms for antiviral innate immunity. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. Cell. 2010 May 14;141(4):668-81. Epub 2010 May 6. 10.1016/j.cell.2010.04.018 PubMed 20451243